Pomerantz Law Firm Investigates Potential Securities Claims: Business and Professional Services Sector Under Scrutiny

Investigation Launched by Pomerantz LLP Regarding Profound Medical Corp.

New York, NY – March 27, 2025

Pomerantz LLP, a leading securities law firm, is currently investigating claims on behalf of investors of Profound Medical Corp. (“Profound” or the “Company”) (NASDAQ: PROF). The investigation concerns potential securities laws violations and seeks to recover damages for investors.

Background on Profound Medical Corp.

Profound Medical Corp. is a medical device company focused on commercializing its TULSA-PRO® system, a minimally invasive, image-guided, and robotically-assisted technology designed to provide precise ablation of peripheral nerves. The Company’s technology is intended for the treatment of various types of chronic pain, including neuropathic pain associated with peripheral nerve injuries and cancer-related pain.

Allegations of Securities Law Violations

Pomerantz LLP’s investigation concerns allegations that Profound Medical Corp. and certain of its officers and directors may have made materially false and misleading statements regarding the Company’s business, operations, and financial condition.

Impact on Investors

If you are a shareholder of Profound Medical Corp. and have suffered a financial loss, you can seek to recover your damages. You may, no later than May 24, 2025, request that the Court appoint you as lead plaintiff of the class. Your ability to share in any recovery doesn’t require that you serve as the lead plaintiff.

Effect on the World

The potential securities law violations at Profound Medical Corp. could have a ripple effect on the broader investment community, particularly in the medical device industry. This case serves as a reminder to investors to carefully evaluate the information provided by publicly traded companies and their executives before making investment decisions.

Conclusion

Pomerantz LLP’s investigation into Profound Medical Corp. highlights the importance of transparency and accuracy in corporate communications. As investors, we rely on the information provided by companies to make informed decisions. When that trust is breached, it can result in significant financial losses. If you believe you have been impacted by this situation, we encourage you to contact us to discuss your options.

  • For more information, please contact Danielle Peyton at [email protected] or 646-581-9980, ext. 125.
  • Join the ongoing discussion on our Facebook page: https://www.facebook.com/pomerantzlawfirm/

Leave a Reply